Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Chdi Foundation Inc. has a patent portfolio in the Biotechnology & Pharmaceuticals technology area. There is currently 1 pending office action for the company. This action is assigned to 1 distinct examiner and 1 distinct art unit. The presence of 1 distinct art unit indicates that the company's current Biotechnology & Pharmaceuticals research is being reviewed by 1 specialized group at the USPTO.
ROMERO, KRISTEN WANG is the busiest examiner for the portfolio, currently managing 1 pending office action. The involvement of 1 distinct examiner and 1 distinct art unit shows that the company's current pending matters are concentrated in 1 area of Biotechnology & Pharmaceuticals research. This means that ROMERO, KRISTEN WANG is the sole examiner responsible for the company's active workload. With 1 pending office action and 1 distinct examiner, the prosecution process is concentrated. This profile allows for interaction with the patent office and affects the management of the company's pending intellectual property matters.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROMERO, KRISTEN WANG | 1 | 69.8% | +30.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18521696 | COMPOUNDS, COMPOSITIONS, AND METHODS | ROMERO, KRISTEN WANG | — |
| Art Unit | Apps |
|---|---|
| 1624 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18521696 | COMPOUNDS, COMPOSITIONS, AND METHODS | ROMERO, KRISTEN WANG | 1624 | §112 | Non-Final OA | — | Pending | Nov 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialChdi Foundation Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Kristen Wang Romero has the most, with 1 of Chdi Foundation Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
